Novartis Investigator Site

Boston, Massachusetts 02215

0 studies enrolling now · 3 studies all time

What they study most

Irritable Bowel Syndrome (IBS), Systemic Sclerosis, Scleroderma, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Tolerability of STI571 (Imatinib Mesylate) for the Treatment of Fibrosis in Participants With Systemic Sclerosis — Completed
• A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus — Completed
• Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide — Completed